SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-039173
Filing Date
2023-02-14
Accepted
2023-02-14 16:18:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d440657dsc13ga.htm SC 13G/A 41373
  Complete submission text file 0001193125-23-039173.txt   42767
Mailing Address C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address
Kumar Neil (Filed by) CIK: 0001742485 (see all company filings)

Type: SC 13G/A

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Subject) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91059 | Film No.: 23629631
SIC: 2834 Pharmaceutical Preparations